We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > J&J

News List

How to trump the Trump administration? For J&J, it’s putting list prices in ads before it’s forced to fiercepharma
February 24, 2019
Johnson & Johnson will put list prices in its drug TV ads. It’s the first pharma to announce that plan, self-regulating ahead of a proposed Trump administration rule that would force all pharma companies to add list prices to TV commercials.
Justice Department, SEC subpoenas put J&J's talc woes under federal microscope fiercepharma
February 24, 2019
Last month, a prominent U.S. senator asked Johnson & Johnson to turn over documents related to asbestos testing at the center of a set of lawsuits linking its iconic baby powder to cancer. But a new J&J disclosure shows it has bigger problems on its hands
Novartis’ Cosentyx beats J&J’s Stelara in psoriasis trial pharmatimes
January 17, 2018
Novartis has released trial data showing that Cosentyx was “significantly more effective” than Johnson & Johnson’s rival biologic Stelara in achieving clear skin in patients with psoriasis.